Description: Synjardy is a combination medication used to manage type 2 diabetes. Each tablet contains 12.5 mg of empagliflozin and 1000 mg of metformin hydrochloride. This dual-action formula helps control blood sugar levels by increasing glucose excretion through the urine and improving insulin sensitivity. Synjardy is designed for once-daily dosing to simplify diabetes management.
Ingredients:
- Active Ingredients:
- Empagliflozin 12.5 mg
- Metformin Hydrochloride 1000 mg
- Excipients: Microcrystalline Cellulose, Croscarmellose Sodium, Magnesium Stearate, Hypromellose, Titanium Dioxide, and other non-active components.
Usage Instructions:
- Take one tablet of Synjardy once daily with meals.
- Swallow the tablet whole; do not crush or chew.
- Follow the dosage prescribed by your healthcare provider.
- Monitor blood sugar levels regularly as advised by your healthcare provider.
Benefits:
- Effectively lowers blood sugar levels in adults with type 2 diabetes.
- Combines two complementary mechanisms to manage diabetes: increased glucose excretion and improved insulin sensitivity.
- Simplifies treatment with a single daily dose.
- Helps reduce the risk of diabetes-related complications.
Precautions:
- Not recommended for use in patients with severe renal impairment, hepatic impairment, or hypersensitivity to empagliflozin, metformin, or any of the excipients.
- Monitor for signs of lactic acidosis, especially in patients with renal issues.
- Use with caution in patients with a history of diabetic ketoacidosis or severe gastrointestinal issues.
- Potential side effects include gastrointestinal disturbances, urinary tract infections, and dehydration.
Storage Instructions:
- Store at room temperature (15°C to 30°C).
- Keep in a dry place, away from direct sunlight and moisture.
- Keep out of reach of children.
Manufacturer: Boehringer Ingelheim Pharmaceuticals, Inc.
